These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11567766)

  • 21. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
    Brayden DJ; Jepson MA; Baird AW
    Drug Discov Today; 2005 Sep; 10(17):1145-57. PubMed ID: 16182207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Rieser C; Wick G; Wolf H
    Int Arch Allergy Immunol; 1997 Aug; 113(4):424-31. PubMed ID: 9250588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectin binding defines and differentiates M-cells in mouse small intestine and caecum.
    Clark MA; Jepson MA; Hirst BH
    Histochem Cell Biol; 1995 Aug; 104(2):161-8. PubMed ID: 8536073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Ulex europaeus agglutinin I-modified liposomes for oral vaccine: Ex Vivo bioadhesion and in Vivo immunity.
    Li K; Zhao X; Xu S; Pang D; Yang C; Chen D
    Chem Pharm Bull (Tokyo); 2011; 59(5):618-23. PubMed ID: 21532200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
    Shakweh M; Ponchel G; Fattal E
    Expert Opin Drug Deliv; 2004 Nov; 1(1):141-63. PubMed ID: 16296726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria.
    Kernéis S; Bogdanova A; Kraehenbuhl JP; Pringault E
    Science; 1997 Aug; 277(5328):949-52. PubMed ID: 9252325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural study of liposome uptake by M cells of rat Peyer's patch: an oral vaccine system for delivery of purified antigen.
    Childers NK; Denys FR; McGee NF; Michalek SM
    Reg Immunol; 1990; 3(1):8-16. PubMed ID: 2223559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer.
    Misumi S; Masuyama M; Takamune N; Nakayama D; Mitsumata R; Matsumoto H; Urata N; Takahashi Y; Muneoka A; Sukamoto T; Fukuzaki K; Shoji S
    J Immunol; 2009 May; 182(10):6061-70. PubMed ID: 19414757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells.
    Pappo J; Ermak TH; Steger HJ
    Immunology; 1991 Jul; 73(3):277-80. PubMed ID: 1879877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of lectin-binding sites defines mouse intestinal M-cells.
    Clark MA; Jepson MA; Simmons NL; Booth TA; Hirst BH
    J Histochem Cytochem; 1993 Nov; 41(11):1679-87. PubMed ID: 7691933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards targeting strategies for oral immunization--identification of marker antigens in rat M cells.
    Rautenberg K; Cichon C; Schmidt MA
    Behring Inst Mitt; 1997 Feb; (98):361-75. PubMed ID: 9382761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.
    Manocha M; Pal PC; Chitralekha KT; Thomas BE; Tripathi V; Gupta SD; Paranjape R; Kulkarni S; Rao DN
    Vaccine; 2005 Dec; 23(48-49):5599-617. PubMed ID: 16099080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral vaccination in man using antigens in particles: current status.
    Brayden DJ
    Eur J Pharm Sci; 2001 Oct; 14(3):183-9. PubMed ID: 11576821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells.
    Jepson MA; Simmons NL; O'Hagan DT; Hirst BH
    J Drug Target; 1993; 1(3):245-9. PubMed ID: 8069566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.
    van der Lubben IM; van Opdorp FA; Hengeveld MR; Onderwater JJ; Koerten HK; Verhoef JC; Borchard G; Junginger HE
    J Drug Target; 2002 Sep; 10(6):449-56. PubMed ID: 12575734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant.
    Kim JI; Park TE; Maharjan S; Li HS; Lee HB; Kim IS; Piao D; Lee JY; Cho CS; Bok JD; Hong ZS; Kang SK; Choi YJ
    BMC Immunol; 2015 Nov; 16():71. PubMed ID: 26608025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral microparticulate vaccine for melanoma using M-cell targeting.
    D'Souza B; Bhowmik T; Shashidharamurthy R; Oettinger C; Selvaraj P; D'Souza M
    J Drug Target; 2012 Feb; 20(2):166-73. PubMed ID: 21981679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of specialized epithelial cells on the bronchus-associated lymphoid tissue (BALT) in the mouse.
    Tango M; Suzuki E; Gejyo F; Ushiki T
    Arch Histol Cytol; 2000 Mar; 63(1):81-9. PubMed ID: 10770591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells.
    Zhao X; Sato A; Dela Cruz CS; Linehan M; Luegering A; Kucharzik T; Shirakawa AK; Marquez G; Farber JM; Williams I; Iwasaki A
    J Immunol; 2003 Sep; 171(6):2797-803. PubMed ID: 12960300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.